BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 23754319)

  • 1. Autophagy enhances antitumor immune responses induced by irradiated hepatocellular carcinoma cells engineered to express hepatitis B virus X protein.
    Yan Y; Liu N; Lu L; Zang CM; Shao B; Li Y; Wen Y; Wei Y; Cheng P
    Oncol Rep; 2013 Aug; 30(2):993-9. PubMed ID: 23754319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiepitope peptide-loaded virus-like particles as a vaccine against hepatitis B virus-related hepatocellular carcinoma.
    Ding FX; Wang F; Lu YM; Li K; Wang KH; He XW; Sun SH
    Hepatology; 2009 May; 49(5):1492-502. PubMed ID: 19206147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local delivery of recombinant adenovirus expressing hepatitis B virus X protein and interleukin-12 results in antitumor effects via inhibition of hepatoma cell growth and intervention of tumor microenvironment.
    He H; Fan P; Yin T; Chen Q; Shi H; Liu S; Li H; Jing Q; Yan Y; Zhang H; Yang L; Wen Y; Li Y; Cheng P
    Int J Mol Med; 2012 Sep; 30(3):599-605. PubMed ID: 22710287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Listeria monocytogenes-based vaccine against hepatocellular carcinoma.
    Chen Y; Yang D; Li S; Gao Y; Jiang R; Deng L; Frankel FR; Sun B
    Oncogene; 2012 Apr; 31(17):2140-52. PubMed ID: 21927025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T lymphocyte responses against hepatitis B virus-related hepatocellular carcinoma induced by adenovirus vaccine encoding HBx.
    Li Y; Cheng P; Wen Y; Chen P; Yang L; Zhao X; Lv H; Quan Q; Wu Y; Yang H; Liu J; Wen X; Liu N; Kang Z; Luo S; Wang L; Wei Y
    Int J Mol Med; 2010 Dec; 26(6):869-76. PubMed ID: 21042781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.
    Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y
    Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
    Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.
    Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC
    Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knock-down of hepatitis B virus X protein reduces the tumorigenicity of hepatocellular carcinoma cells.
    Chan DW; Ng IO
    J Pathol; 2006 Feb; 208(3):372-80. PubMed ID: 16353167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gene expression profile in response to hepatitis B virus X gene by using an adenoviral vector].
    Joo HY; Han KH; Ryu WS
    Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):371-80. PubMed ID: 12506241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus X protein promotes interleukin-7 receptor expression via NF-κB and Notch1 pathway to facilitate proliferation and migration of hepatitis B virus-related hepatoma cells.
    Kong F; Hu W; Zhou K; Wei X; Kou Y; You H; Zheng K; Tang R
    J Exp Clin Cancer Res; 2016 Nov; 35(1):172. PubMed ID: 27821177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibition of HBV DNA replication and expression in 2.2.15 hepatoma cells infected with AFP-mediated HBX antisense RNA].
    Ma CH; Sun WS; Liu SX; Wang XY; Zhang LN; Cao YL; Han LH
    Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):291-4. PubMed ID: 12773245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression.
    Wu CS; Yen CJ; Chou RH; Chen JN; Huang WC; Wu CY; Yu YL
    Int J Cancer; 2014 Apr; 134(7):1638-47. PubMed ID: 24122375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
    Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
    J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus X protein stimulates IL-6 expression in hepatocytes via a MyD88-dependent pathway.
    Xiang WQ; Feng WF; Ke W; Sun Z; Chen Z; Liu W
    J Hepatol; 2011 Jan; 54(1):26-33. PubMed ID: 20937539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma.
    Qiu X; Dong S; Qiao F; Lu S; Song Y; Lao Y; Li Y; Zeng T; Hu J; Zhang L; Zhang L; Fan H
    Oncogene; 2013 Jul; 32(27):3296-305. PubMed ID: 23604124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sorafenib overcomes the chemoresistance in HBx-expressing hepatocellular carcinoma cells through down-regulation of HBx protein stability and suppresses HBV gene expression.
    Kim HY; Jung HU; Yoo SH; Yoo KS; Cheong J; Park BS; Yun I; Yoo YH
    Cancer Lett; 2014 Dec; 355(1):61-9. PubMed ID: 25218348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx.
    Sirma H; Giannini C; Poussin K; Paterlini P; Kremsdorf D; Bréchot C
    Oncogene; 1999 Aug; 18(34):4848-59. PubMed ID: 10490818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients.
    Shang XY; Chen HS; Zhang HG; Pang XW; Qiao H; Peng JR; Qin LL; Fei R; Mei MH; Leng XS; Gnjatic S; Ritter G; Simpson AJ; Old LJ; Chen WF
    Clin Cancer Res; 2004 Oct; 10(20):6946-55. PubMed ID: 15501973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.